Softcell Medical secured investment and grant funding in September 2017

Softcell Medical Ltd, a privately-held medical device company, has secured significant private investment and grant funding to finance the development of its pH monitoring technology.

Currently, no equipment exists that can provide clinicians with real time information about the metabolic state of the muscles within the limbs, that account for approximately 35-40% of the body’s circulation.

The patented technology developed by Softcell, is a novel pH monitoring system that for the first time provides surgeons with real time monitoring of muscle cell health. Based upon our clinical studies, pH monitoring will enable clinicians to quickly recognise symptoms of muscle cell distress and take remedial action before the onset of permanent damage.

Back to All News